• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
A20010017 布地奈德/福莫特罗吸入粉雾剂 budesonide;formoterol fumarate Inhalation Chemical Drugs New Drug Application 2001-05-11 阿斯特拉(无锡)制药有限公司 Astrazeneca Pharmaceutical Co Ltd Approval Completed-Pending Certificated 2003-01-24 view
JYHB1701500 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-12-13 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-03-20 view
JYHB1701492 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-11-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-02-02 view
JYHB1701499 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-12-13 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-03-20 view
JYHZ1800449 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs License Renew 2018-12-26 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-05-20 view
JYHB1701491 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-11-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-02-02 view
JYHB1701498 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-12-13 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-03-20 view
JYHZ1800448 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs License Renew 2018-12-26 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-05-20 view
JYHZ1800447 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs License Renew 2018-12-26 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-05-20 view
JYHB1701490 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2017-11-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-02-02 view
JXHL1400062 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Import Drug Application 2014-03-12 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Certificate Issued 2015-04-20 view
JXHL1400063 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Import Drug Application 2014-03-10 阿斯利康制药有限公司 Astrazeneca Pharmaceutical Co Ltd Certificate Issued 2015-04-20 view
CXHL1402182 布地奈德福莫特罗粉吸入剂(胶囊型) budesonide;formoterol fumarate Inhalation Chemical Drugs(5) New Drug Application 2015-01-14 正大天晴药业集团股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Certificate Issued 2016-10-27 view
CXLB00010 布地奈德/福莫特罗复方粉雾吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs(3) New Drug Application 2000-11-24 北京阿里斯临床研究有限公司 In Approval view
JXHL1500229 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Import Drug Application 2015-09-09 Teva Pharma B.V. Teva Pharma BV Certificate Issued 2018-08-16 view
JXHL1500230 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Import Drug Application 2015-09-09 Teva Pharma B.V. Teva Pharma BV Certificate Issued 2018-08-16 view
JYHB0500728 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2005-11-09 Draco Lakemedel AB Draco Lakemedel AB Certificate Issued 2006-03-23 view
JYHB0500726 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2005-11-09 Draco Lakemedel AB Draco Lakemedel AB Certificate Issued 2006-03-23 view
JYHB0500727 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2005-11-09 Draco Lakemedel AB Draco Lakemedel AB Certificate Issued 2006-03-23 view
J0400059 布地奈德福莫特罗粉吸入剂 budesonide;formoterol fumarate Inhalation Chemical Drugs Supplementary Application 2004-06-11 AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.) AstraZeneca AB Pending Approval 2005-01-24 view